The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ophthalmic Therapeutics & Drug Market Research Report 2025
Synopsis
The global Ophthalmic Therapeutics & Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Therapeutics & Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Therapeutics & Drug.
Report Scope
The Ophthalmic Therapeutics & Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Therapeutics & Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Therapeutics & Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Segment by Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Segment by Application
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Therapeutics & Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Ophthalmic Therapeutics & Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Therapeutics & Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Therapeutics & Drug.
Report Scope
The Ophthalmic Therapeutics & Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Therapeutics & Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Therapeutics & Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Segment by Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Segment by Application
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Therapeutics & Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Therapeutics & Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-allergy
1.2.3 Anti-VEGF Agents
1.2.4 Anti-inflammatory
1.2.5 Anti-glaucoma
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Therapeutics & Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dry Eye
1.3.3 Allergies
1.3.4 Glaucoma
1.3.5 Infection
1.3.6 Retinal Disorders
1.3.7 Uveitis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Therapeutics & Drug Market Perspective (2019-2030)
2.2 Ophthalmic Therapeutics & Drug Growth Trends by Region
2.2.1 Global Ophthalmic Therapeutics & Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ophthalmic Therapeutics & Drug Historic Market Size by Region (2019-2024)
2.2.3 Ophthalmic Therapeutics & Drug Forecasted Market Size by Region (2025-2030)
2.3 Ophthalmic Therapeutics & Drug Market Dynamics
2.3.1 Ophthalmic Therapeutics & Drug Industry Trends
2.3.2 Ophthalmic Therapeutics & Drug Market Drivers
2.3.3 Ophthalmic Therapeutics & Drug Market Challenges
2.3.4 Ophthalmic Therapeutics & Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Therapeutics & Drug Players by Revenue
3.1.1 Global Top Ophthalmic Therapeutics & Drug Players by Revenue (2019-2024)
3.1.2 Global Ophthalmic Therapeutics & Drug Revenue Market Share by Players (2019-2024)
3.2 Global Ophthalmic Therapeutics & Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ophthalmic Therapeutics & Drug Revenue
3.4 Global Ophthalmic Therapeutics & Drug Market Concentration Ratio
3.4.1 Global Ophthalmic Therapeutics & Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics & Drug Revenue in 2023
3.5 Ophthalmic Therapeutics & Drug Key Players Head office and Area Served
3.6 Key Players Ophthalmic Therapeutics & Drug Product Solution and Service
3.7 Date of Enter into Ophthalmic Therapeutics & Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Therapeutics & Drug Breakdown Data by Type
4.1 Global Ophthalmic Therapeutics & Drug Historic Market Size by Type (2019-2024)
4.2 Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Type (2025-2030)
5 Ophthalmic Therapeutics & Drug Breakdown Data by Application
5.1 Global Ophthalmic Therapeutics & Drug Historic Market Size by Application (2019-2024)
5.2 Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ophthalmic Therapeutics & Drug Market Size (2019-2030)
6.2 North America Ophthalmic Therapeutics & Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024)
6.4 North America Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ophthalmic Therapeutics & Drug Market Size (2019-2030)
7.2 Europe Ophthalmic Therapeutics & Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024)
7.4 Europe Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Therapeutics & Drug Market Size (2019-2030)
8.2 Asia-Pacific Ophthalmic Therapeutics & Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ophthalmic Therapeutics & Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Ophthalmic Therapeutics & Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ophthalmic Therapeutics & Drug Market Size (2019-2030)
9.2 Latin America Ophthalmic Therapeutics & Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024)
9.4 Latin America Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Therapeutics & Drug Market Size (2019-2030)
10.2 Middle East & Africa Ophthalmic Therapeutics & Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alcon
11.1.1 Alcon Company Detail
11.1.2 Alcon Business Overview
11.1.3 Alcon Ophthalmic Therapeutics & Drug Introduction
11.1.4 Alcon Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.1.5 Alcon Recent Development
11.2 Johnson and Johnson Vision Care, Inc.
11.2.1 Johnson and Johnson Vision Care, Inc. Company Detail
11.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Introduction
11.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
11.3 Bausch & Lomb Incorporated
11.3.1 Bausch & Lomb Incorporated Company Detail
11.3.2 Bausch & Lomb Incorporated Business Overview
11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Introduction
11.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.3.5 Bausch & Lomb Incorporated Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Ophthalmic Therapeutics & Drug Introduction
11.4.4 Novartis AG Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Merck Sharp & Dohme Corp.
11.5.1 Merck Sharp & Dohme Corp. Company Detail
11.5.2 Merck Sharp & Dohme Corp. Business Overview
11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Introduction
11.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.5.5 Merck Sharp & Dohme Corp. Recent Development
11.6 Regeneron Pharmaceuticals Inc.
11.6.1 Regeneron Pharmaceuticals Inc. Company Detail
11.6.2 Regeneron Pharmaceuticals Inc. Business Overview
11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Introduction
11.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.6.5 Regeneron Pharmaceuticals Inc. Recent Development
11.7 Allergan
11.7.1 Allergan Company Detail
11.7.2 Allergan Business Overview
11.7.3 Allergan Ophthalmic Therapeutics & Drug Introduction
11.7.4 Allergan Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.7.5 Allergan Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Detail
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Ophthalmic Therapeutics & Drug Introduction
11.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.8.5 Pfizer Inc. Recent Development
11.9 Valeant
11.9.1 Valeant Company Detail
11.9.2 Valeant Business Overview
11.9.3 Valeant Ophthalmic Therapeutics & Drug Introduction
11.9.4 Valeant Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.9.5 Valeant Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Detail
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Ophthalmic Therapeutics & Drug Introduction
11.10.4 Bayer AG Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.10.5 Bayer AG Recent Development
11.11 Santen Pharmaceuticals Co. Ltd
11.11.1 Santen Pharmaceuticals Co. Ltd Company Detail
11.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
11.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Introduction
11.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.11.5 Santen Pharmaceuticals Co. Ltd Recent Development
11.12 Genentech, Inc.
11.12.1 Genentech, Inc. Company Detail
11.12.2 Genentech, Inc. Business Overview
11.12.3 Genentech, Inc. Ophthalmic Therapeutics & Drug Introduction
11.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024)
11.12.5 Genentech, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ophthalmic Therapeutics & Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anti-allergy
Table 3. Key Players of Anti-VEGF Agents
Table 4. Key Players of Anti-inflammatory
Table 5. Key Players of Anti-glaucoma
Table 6. Key Players of Others
Table 7. Global Ophthalmic Therapeutics & Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Ophthalmic Therapeutics & Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Ophthalmic Therapeutics & Drug Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Ophthalmic Therapeutics & Drug Market Share by Region (2019-2024)
Table 11. Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Ophthalmic Therapeutics & Drug Market Share by Region (2025-2030)
Table 13. Ophthalmic Therapeutics & Drug Market Trends
Table 14. Ophthalmic Therapeutics & Drug Market Drivers
Table 15. Ophthalmic Therapeutics & Drug Market Challenges
Table 16. Ophthalmic Therapeutics & Drug Market Restraints
Table 17. Global Ophthalmic Therapeutics & Drug Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Ophthalmic Therapeutics & Drug Market Share by Players (2019-2024)
Table 19. Global Top Ophthalmic Therapeutics & Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutics & Drug as of 2023)
Table 20. Ranking of Global Top Ophthalmic Therapeutics & Drug Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Ophthalmic Therapeutics & Drug Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ophthalmic Therapeutics & Drug Product Solution and Service
Table 24. Date of Enter into Ophthalmic Therapeutics & Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ophthalmic Therapeutics & Drug Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Ophthalmic Therapeutics & Drug Revenue Market Share by Type (2019-2024)
Table 28. Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Ophthalmic Therapeutics & Drug Revenue Market Share by Type (2025-2030)
Table 30. Global Ophthalmic Therapeutics & Drug Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Ophthalmic Therapeutics & Drug Revenue Market Share by Application (2019-2024)
Table 32. Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Ophthalmic Therapeutics & Drug Revenue Market Share by Application (2025-2030)
Table 34. North America Ophthalmic Therapeutics & Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Ophthalmic Therapeutics & Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Ophthalmic Therapeutics & Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Ophthalmic Therapeutics & Drug Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Ophthalmic Therapeutics & Drug Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Ophthalmic Therapeutics & Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Ophthalmic Therapeutics & Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Ophthalmic Therapeutics & Drug Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Ophthalmic Therapeutics & Drug Market Size by Country (2025-2030) & (US$ Million)
Table 49. Alcon Company Detail
Table 50. Alcon Business Overview
Table 51. Alcon Ophthalmic Therapeutics & Drug Product
Table 52. Alcon Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 53. Alcon Recent Development
Table 54. Johnson and Johnson Vision Care, Inc. Company Detail
Table 55. Johnson and Johnson Vision Care, Inc. Business Overview
Table 56. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Product
Table 57. Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 58. Johnson and Johnson Vision Care, Inc. Recent Development
Table 59. Bausch & Lomb Incorporated Company Detail
Table 60. Bausch & Lomb Incorporated Business Overview
Table 61. Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Product
Table 62. Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 63. Bausch & Lomb Incorporated Recent Development
Table 64. Novartis AG Company Detail
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Ophthalmic Therapeutics & Drug Product
Table 67. Novartis AG Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 68. Novartis AG Recent Development
Table 69. Merck Sharp & Dohme Corp. Company Detail
Table 70. Merck Sharp & Dohme Corp. Business Overview
Table 71. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Product
Table 72. Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 73. Merck Sharp & Dohme Corp. Recent Development
Table 74. Regeneron Pharmaceuticals Inc. Company Detail
Table 75. Regeneron Pharmaceuticals Inc. Business Overview
Table 76. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Product
Table 77. Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 78. Regeneron Pharmaceuticals Inc. Recent Development
Table 79. Allergan Company Detail
Table 80. Allergan Business Overview
Table 81. Allergan Ophthalmic Therapeutics & Drug Product
Table 82. Allergan Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 83. Allergan Recent Development
Table 84. Pfizer Inc. Company Detail
Table 85. Pfizer Inc. Business Overview
Table 86. Pfizer Inc. Ophthalmic Therapeutics & Drug Product
Table 87. Pfizer Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 88. Pfizer Inc. Recent Development
Table 89. Valeant Company Detail
Table 90. Valeant Business Overview
Table 91. Valeant Ophthalmic Therapeutics & Drug Product
Table 92. Valeant Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 93. Valeant Recent Development
Table 94. Bayer AG Company Detail
Table 95. Bayer AG Business Overview
Table 96. Bayer AG Ophthalmic Therapeutics & Drug Product
Table 97. Bayer AG Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 98. Bayer AG Recent Development
Table 99. Santen Pharmaceuticals Co. Ltd Company Detail
Table 100. Santen Pharmaceuticals Co. Ltd Business Overview
Table 101. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Product
Table 102. Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 103. Santen Pharmaceuticals Co. Ltd Recent Development
Table 104. Genentech, Inc. Company Detail
Table 105. Genentech, Inc. Business Overview
Table 106. Genentech, Inc. Ophthalmic Therapeutics & Drug Product
Table 107. Genentech, Inc. Revenue in Ophthalmic Therapeutics & Drug Business (2019-2024) & (US$ Million)
Table 108. Genentech, Inc. Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmic Therapeutics & Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ophthalmic Therapeutics & Drug Market Share by Type: 2023 VS 2030
Figure 3. Anti-allergy Features
Figure 4. Anti-VEGF Agents Features
Figure 5. Anti-inflammatory Features
Figure 6. Anti-glaucoma Features
Figure 7. Others Features
Figure 8. Global Ophthalmic Therapeutics & Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Ophthalmic Therapeutics & Drug Market Share by Application: 2023 VS 2030
Figure 10. Dry Eye Case Studies
Figure 11. Allergies Case Studies
Figure 12. Glaucoma Case Studies
Figure 13. Infection Case Studies
Figure 14. Retinal Disorders Case Studies
Figure 15. Uveitis Case Studies
Figure 16. Others Case Studies
Figure 17. Ophthalmic Therapeutics & Drug Report Years Considered
Figure 18. Global Ophthalmic Therapeutics & Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Ophthalmic Therapeutics & Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Ophthalmic Therapeutics & Drug Market Share by Region: 2023 VS 2030
Figure 21. Global Ophthalmic Therapeutics & Drug Market Share by Players in 2023
Figure 22. Global Top Ophthalmic Therapeutics & Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutics & Drug as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutics & Drug Revenue in 2023
Figure 24. North America Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Ophthalmic Therapeutics & Drug Market Share by Country (2019-2030)
Figure 26. United States Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Ophthalmic Therapeutics & Drug Market Share by Country (2019-2030)
Figure 30. Germany Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Ophthalmic Therapeutics & Drug Market Share by Region (2019-2030)
Figure 38. China Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Ophthalmic Therapeutics & Drug Market Share by Country (2019-2030)
Figure 46. Mexico Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Ophthalmic Therapeutics & Drug Market Share by Country (2019-2030)
Figure 50. Turkey Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Ophthalmic Therapeutics & Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Alcon Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 53. Johnson and Johnson Vision Care, Inc. Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 54. Bausch & Lomb Incorporated Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 55. Novartis AG Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 56. Merck Sharp & Dohme Corp. Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 57. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 58. Allergan Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 59. Pfizer Inc. Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 60. Valeant Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 61. Bayer AG Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 62. Santen Pharmaceuticals Co. Ltd Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 63. Genentech, Inc. Revenue Growth Rate in Ophthalmic Therapeutics & Drug Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
